Catalog No.
RVV11602
Species reactivity
Canine parvovirus type 2 (CPV-2)
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400, IF: 1:200-1:1000, IHC: 1:200-1:1000, WB: 1:500-1:2000
Target
Capsid protein VP2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Applications
ELISA, FCM, IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R4D72
In silico designing of multi-epitope vaccine against canine parvovirus using reverse vaccinology., PMID:39060911
A novel lateral flow immunochromatographic assay using a recombinant VP2 antigen for total antibody detection of canine parvovirus-2., PMID:38186287
Administration with Vaccinia Virus Encoding Canine Parvovirus 2 vp2 Elicits Systemic Immune Responses in Mice and Dogs., PMID:32364832
Identification and characterization of a novel B-cell epitope on Aleutian Mink Disease virus capsid protein VP2 using a monoclonal antibody., PMID:29278728
Global displacement of canine parvovirus by a host-adapted variant: structural comparison between pandemic viruses with distinct host ranges., PMID:25410876
Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure., PMID:24486948
Recombinant ELISA using baculovirus-expressed VP2 for detection of antibodies against canine parvovirus., PMID:22664182
Genetic analysis of canine parvovirus isolates (CPV-2) from dogs in Italy., PMID:11864747
Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan., PMID:8128593
For research use only. Not for human or drug use.
